Instil Bio Reports Q3 2026 Net Loss of $4.2 Million and $67.1 Million in Cash and Investments
Instil Bio reported a third-quarter 2026 net loss of $4.2 million, or $0.62 per share, compared with a $13.6 million net loss a year earlier. The company ended September with $67.1 million in cash, restricted cash, marketable securities and long-term investments, which it expects to fund its curren…